Article Text

Download PDFPDF
Assessing the understanding and prior uptake of human papillomavirus vaccination among eligible females attending genitourinary medicine clinics in UK
  1. E J McCarty1,
  2. C O'Mahony2,
  3. S Bates3,
  4. P Fox4,
  5. R D Maw1
  1. 1Department of Genitourinary Medicine, Royal Victoria Hospital, Belfast Health and Social Care Trust, UK
  2. 2Department of Genitourinary Medicine, Countess of Chester Foundation Trust Hospital, Chester, UK
  3. 3Department of Genitourinary Medicine, Royal Hallisham Hospital, Sheffield Teaching Hospitals, UK
  4. 4Department of Genitourinary Medicine, Ealing Hospital, Southall, UK
  1. Correspondence to E J McCarty, Department of Genitourinary Medicine, Royal Victoria Hospital, Grosvenor Road, Belfast BT12 6AB, UK; ej_mccarty{at}

Statistics from

In 2008, the UK human papillomavirus vaccination programme was introduced to vaccinate all 12–13-year-old girls, with a 2-year catch up for those aged up to 18 years. Delivery has been principally through schools and general practitioners, although concern remains that all groups are not being reached and the full three doses may not be received by all. Many young sexually active females attend genitourinary medicine (GUM) clinics; therefore, this may be a potential location for vaccine delivery.

In order to assess knowledge and prior vaccine uptake, a survey …

View Full Text


  • Competing interests None.

  • Ethics approval Northern Ireland Ethics Committee.

  • Provenance and peer review Not commissioned; internally peer reviewed.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.